RVRC (Revium Recovery) Buildings And Improvements : $0.00 Mil (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is Revium Recovery Buildings And Improvements?

Revium Recovery Buildings And Improvements Historical Data

The historical data trend for Revium Recovery's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revium Recovery Buildings And Improvements Chart

Revium Recovery Annual Data

Trend

Buildings And Improvements

Revium Recovery Semi-Annual Data

Buildings And Improvements

Revium Recovery Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Revium Recovery Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Revium Recovery Inc (OTCPK:RVRC) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 HaMenofim Street, Herzliya, ISR, 4672561

Website

https://www.reviumrecovery.com

Revium Recovery Inc is focused on developing cutting-edge nano-medicines to deliver treatment solutions for diseases with limited or no effective medical options. LipoVation has exclusive license rights to develop and market a novel technology related to Nano-Liposomal Particles (NLP) based medicines, including: novel formulation of a potent antibiotic which shows promise in combating several life-threatening antibiotic-resistant bacteria which currently have no available treatment, Novel adjuvant to cancer therapies, and novel immunization approach based on Liposomal Protein-Loaded Technology (LPLT).